TrialJournal of atherosclerosis and thrombosis2022

Differential Effects of DPP-4 Inhibitors, Anagliptin and Sitagliptin, on PCSK9 Levels in Patients with Type 2 Diabetes Mellitus who are Receiving Statin Therapy.

Masato Furuhashi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.